A

Annovis Bio

ANVS

9.14000
USD
-0.2
(-2.14%)
Market Closed
Volume
4,030
EPS
0
Div Yield
0
P/E
-2
Market Cap
125,710,193
OverviewSignalsIdeasNews
Related Instruments
A
ALNY
31.19
(13.13%)
268.66 USD
AZN
2.040
(2.58%)
81.200 USD
B
BMRN
0.270
(0.32%)
84.620 USD
BMY
0.620
(1.30%)
48.180 USD
C
CRVS
0.36000
(13.85%)
2.96000 USD
F
FATE
-0.46000
(-8.61%)
4.88000 USD
GSK
0.865
(2.23%)
39.650 USD
MRNA
-25.020
(-20.99%)
94.160 USD
NVS
0.650
(0.58%)
112.100 USD
PFE
0.115
(0.38%)
30.650 USD
X
XNCR
-0.600
(-2.93%)
19.880 USD
News

Novo Nordisk Surges in Profit and Sales

5 months ago
Stocks news

Title: Annovis Bio

Sector: Healthcare
Industry: Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.